Targeting B-cell Subsets in Type 1 Diabetes: Possible Routes to Therapy?
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Boldison J, Hopkinson J, Davies J, Pearson J, Leete P, Richardson S
. Gene expression profiling in NOD mice reveals that B cells are highly educated by the pancreatic environment during autoimmune diabetes. Diabetologia. 2022; 66(3):551-566.
PMC: 9892163.
DOI: 10.1007/s00125-022-05839-7.
View
2.
Korpos E, Kadri N, Loismann S, Findeisen C, Arfuso F, Burke 3rd G
. Identification and characterisation of tertiary lymphoid organs in human type 1 diabetes. Diabetologia. 2021; 64(7):1626-1641.
PMC: 8187221.
DOI: 10.1007/s00125-021-05453-z.
View
3.
Smith M, Boldison J, Wong F
. The Role of B Lymphocytes in Type 1 Diabetes. Cold Spring Harb Perspect Med. 2024; .
DOI: 10.1101/cshperspect.a041593.
View
4.
Pescovitz M, Greenbaum C, Krause-Steinrauf H, Becker D, Gitelman S, Goland R
. Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. N Engl J Med. 2009; 361(22):2143-52.
PMC: 6410357.
DOI: 10.1056/NEJMoa0904452.
View
5.
Willcox A, Richardson S, Bone A, Foulis A, Morgan N
. Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol. 2009; 155(2):173-81.
PMC: 2675247.
DOI: 10.1111/j.1365-2249.2008.03860.x.
View